Access Bio Inc Total Liabilities

Latest as of June 2025: ₩67.08 Billion KRW ≈ $45.46 Million USD

Access Bio Inc total liabilities. Based on the latest financial reports, Access Bio Inc (950130) has total liabilities worth ₩67.08 Billion KRW (≈ $45.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 950130 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Access Bio Inc (2012–2024)

Total liabilities of Access Bio Inc from 2012 to 2024. This chart illustrates how Access Bio Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Access Bio Inc to see how much of total assets are deployed in long-term investments.

Access Bio Inc Competitors by Total Liabilities

The table below lists competitors of Access Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Ssangyong Information & Communications Corp KQ:010280	Korea	₩203.54 Billion
Orbis AG XETRA:OBS	Germany	€45.64 Million
Mustek Ltd JSE:MST	South Africa	ZAC2.48 Billion
Samho Dev KO:010960	Korea	₩116.05 Billion
Global Knafaim Leasing Ltd TA:GKL	Israel	ILA49.12 Million
Manuka Resources Ltd AU:MKR	Australia	AU$38.06 Million
Grazziotin S.A SA:CGRA3	Brazil	R$372.38 Million
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	Germany	€1.05 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Access Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Access Bio Inc.

Liquidity & Leverage Metrics

Access Bio Inc Total Liabilities Ratios Explained

Access Bio Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	15.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Access Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Access Bio Inc (2012–2024)

The table below shows the annual total liabilities of Access Bio Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩61.70 Million ≈ $41.81K	-99.94%
2023-12-31	₩104.00 Billion ≈ $70.48 Million	+49192.84%
2022-12-31	₩210.97 Million ≈ $142.97K	+60.93%
2021-12-31	₩131.10 Million ≈ $88.84K	+64.97%
2020-12-31	₩79.47 Million ≈ $53.86K	+103.73%
2019-12-31	₩39.01 Million ≈ $26.43K	-24.11%
2018-12-31	₩51.40 Million ≈ $34.83K	+11.67%
2017-12-31	₩46.03 Million ≈ $31.19K	+5.38%
2016-12-31	₩43.68 Million ≈ $29.60K	-98.97%
2015-12-31	₩4.24 Billion ≈ $2.87 Million	-59.04%
2014-12-31	₩10.35 Billion ≈ $7.01 Million	+15.08%
2013-12-31	₩8.99 Billion ≈ $6.09 Million	+21.79%
2012-12-31	₩7.38 Billion ≈ $5.00 Million	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$43.81 Million

₩64.65 Billion KRW

Market Cap Rank

#22193 Global

#1393 in Korea

Share Price

₩1838.00

Change (1 day)

-3.82%

52-Week Range

₩1838.00 - ₩2570.00

All Time High

₩29950.00